2009
DOI: 10.2478/v10043-009-0013-8
|View full text |Cite
|
Sign up to set email alerts
|

Towards the Elimination of the Bioko Form of Simulium Yahense from Bioko: Planning and Insecticide Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…A feasibility study was carried out in 1996, confirming the high vectorial efficiency of the endemic Bioko form of S imulium yahense [ 13 ] and the distribution of the vector breeding sites [ 14 ]. From 2001 to 2005, a large-scale larviciding trial using ground-based applications was undertaken using helicopter and ground-based applications of temephos [ 8 , 15 ]. In 2005, the endemic Bioko form of S .…”
Section: Introductionmentioning
confidence: 99%
“…A feasibility study was carried out in 1996, confirming the high vectorial efficiency of the endemic Bioko form of S imulium yahense [ 13 ] and the distribution of the vector breeding sites [ 14 ]. From 2001 to 2005, a large-scale larviciding trial using ground-based applications was undertaken using helicopter and ground-based applications of temephos [ 8 , 15 ]. In 2005, the endemic Bioko form of S .…”
Section: Introductionmentioning
confidence: 99%
“…This dataset, recording weekly averages of DBRs during 2001 at three different sites (Musola, Barleycorn and Sampaca), was collected as part of APOC pilot studies on the effectiveness and feasibility of localized vector control in the elimination of onchocerciasis from Bioko, an island off the coast of Cameroon and part of Equatorial Guinea. Detailed collection methods were described in [ 29 ]. Bioko is covered by large swathes of forest, and the local onchocerciasis vectors (the Bioko form of S. yahense [ 30 ]) have now been eliminated from the island [ 31 ] (in addition to ivermectin MDA being implemented).…”
Section: Methodsmentioning
confidence: 99%